Gheorghe Doros, PhD
Boston University School of Public Health
Dept of Biostatistics

PhD, Yale University
MA, Yale University
MS, University of Bucharest

Gheorghe Doros is Professor of Biostatistics and director of the Biostatistics Consulting Group. He received his PhD in Statistics from Yale University and joined BUSPH’s Department of Biostatistics in 2006 after spending two years at Eli Lilly, as a member of that company's Drug Discovery and Toxicology department. Dr. Doros’s research on methodological approaches and strategies has been concentrated in the area of clinical trials, more specifically on Bayesian approaches to clinical trials and the area of placebo response in clinical trials. The outcome of his work has been a corner stone in developing a host of collaborations with outstanding faculty, clinicians, and researchers at the Boston University Medical Campus and at other institutions. These productive collaborations have resulted in several federally funded grants. Dr. Doros authored and co-authored many peer-reviewed publications of original and innovative research which has had a major impact on the field. On the majority of publications, Dr. Doros is the lead statistician author. He demonstrated continuing record of multidisciplinary research that has had a major impact on the rapidly changing field. His publications on clinical trials; most proposing the design, analysis and new methodologies or of significant contributions to this field.

Dr. Doros is a very active and effective teacher and mentor in the department of Biostatistics. His teaching philosophy is to pursue an active approach to learning and to engage students to think critically. He taught core and elective courses for Master and PhD-level courses. The excellent course evaluations he received attests to his ability in engaging students in active learning. Dr. Doros has been awarded the excellence in teaching three times in three years.

On a national level, Dr. Doros has served as an Associate Editor for the BioMed Central’s journal Trials and as a reviewer for a number of academic journals. He served as a member of the merit review subcommittee for Epidemiology of the Department of Veteran Affairs and a member NHLBI-Ancillary Studies in Clinical Trials between 2012 and 2014. He has served as a statistical expert on a number of Independent Data Monitoring Committee(IDMC) for clinical trials and clinical programs. He served or seves as a senior consultant on multicenter trials and/or programs for the following organizations Pfizer, Takeda, Avanir, Sarepta and Children's Hospital.

Boston University
BU-BMC Cancer Center

Boston Medical Center

2008-2010 Boston University School of Public Health: Excellence in Teaching Award

VA241-16-D-0012 VA Master Contract Task Order 24
09/01/2020 - 08/31/2021 (PI)
VA Boston Healthcare System

VA241-16-D-0012 VA Master Contract Task Order 19
05/01/2020 - 08/31/2021 (PI)
VA Boston Healthcare System

Gheorghe Doros, PhD: Statistical research in clinical trials (Baim Institute for Clinical Research)
09/01/2017 - 08/31/2021 (PI)
Baim Institute for Clinical Research

VA241-16-D-0012 VA Master Contract Task Order 18
09/01/2019 - 08/31/2020 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
05/01/2016 - 08/31/2019 (PI)
VA Boston Healthcare System

Gheorghe Doros, PhD (faculty): Statistical research in clinical trials (Harvard Clinical Research Institute)
09/01/2016 - 08/31/2017 (PI)
Harvard Clinical Research Institute

Personnel Agreement for Research Services of Gheorghe Doros
06/01/2012 - 02/28/2016 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
07/01/2012 - 05/31/2013 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
08/01/2009 - 03/31/2012 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
06/01/2008 - 03/31/2012 (PI)
VA Boston Healthcare System

Showing 10 of 11 results. Show All Results


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Cheng TW, Maithel SK, Kabutey NK, Fujitani RM, Farber A, Levin SR, Patel VI, Jones DW, Rybin D, Doros G, Siracuse JJ. Access Type for Endovascular Repair in Ruptured Abdominal Aortic Aneurysms Does Not Affect Major Morbidity or Mortality. Ann Vasc Surg. 2020 Jul 10.View Related Profiles. PMID: 32659419
  2. Haider KS, Haider A, Saad F, Doros G, Hanefeld M, Dhindsa S, Dandona P, Traish A. Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study. Diabetes Obes Metab. 2020 Jun 19.View Related Profiles. PMID: 32558149
  3. Kandzari DE, Koolen JJ, Doros G, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE, Waksman R. Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial. JACC Cardiovasc Interv. 2020 06 08; 13(11):1343-1353. PMID: 32499026
  4. Khalid U, Marzec LN, Mantini N, Manson SM, Doros G, Cannon CP, Song Y, Dong L, Hsu JC, Jeong MY, Virani SS, Maddox TM. Treatment of AF in American Indians and Alaska Natives: Insights From the NCDR PINNACLE-AF Registry. J Am Coll Cardiol. 2020 Jun 02; 75(21):2749-2750. PMID: 32466892
  5. Sciria CT, Maddox TM, Marzec L, Rodwin B, Virani SS, Annapureddy A, Freeman JV, O'Hare A, Liu Y, Song Y, Doros G, Zheng Y, Lee JJ, Daggubati R, Vadlamani L, Cannon C, Desai NR. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry. Clin Cardiol. 2020 Jul; 43(7):743-751. PMID: 32378265
  6. Wadhera RK, Bhatt DL, Kind AJH, Song Y, Williams KA, Maddox TM, Yeh RW, Dong L, Doros G, Turchin A, Joynt Maddox KE. Association of Outpatient Practice-Level Socioeconomic Disadvantage With Quality of Care and Outcomes Among Older Adults With Coronary Artery Disease: Implications for Value-Based Payment. Circ Cardiovasc Qual Outcomes. 2020 04; 13(4):e005977. PMID: 32228065
  7. Saad F, Doros G, Haider KS, Haider A. Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study. Int J Obes (Lond). 2020 Jun; 44(6):1264-1278. PMID: 32060355
  8. Bessesen MT, Doros G, Henrie AM, Harrington KM, Hermos JA, Bonomo RA, Ferguson RE, Huang GD, Brown ST. A multicenter randomized placebo controlled trial of rifampin to reduce pedal amputations for osteomyelitis in veterans with diabetes (VA INTREPID). BMC Infect Dis. 2020 Jan 08; 20(1):23.View Related Profiles. PMID: 31914940
  9. Wilson BM, Bessesen MT, Doros G, Brown ST, Saade E, Hermos J, Perez F, Skalweit M, Spellberg B, Bonomo RA. Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration. JAMA Netw Open. 2019 11 01; 2(11):e1916003. PMID: 31755948
  10. Lilleness B, Doros G, Ruberg FL, Sanchorawala V. Establishment of brain natriuretic peptide - based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosis. Br J Haematol. 2020 02; 188(3):424-427.View Related Profiles. PMID: 31515797
Showing 10 of 303 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 303 publications over 18 distinct years, with a maximum of 41 publications in 2014

Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Doros's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department